MedTrace Logo

Pilot Study of the Contour Neurovascular SystemTM

NCT02784431 · Status: TERMINATED · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2022-07-26

Study results available
· View outcomes & findings →

Summary

Prospective, single arm, multi centre study to evaluate the safety and performance of the Contour Neurovascular SystemTM in the treatment of intracranial aneurysm (IA)

Conditions

  • Intracranial Aneurysm

Interventions

DEVICE

Contour Neurovascular System placement

Patients who meet the eligibility criteria will have their target aneurysm treated with the Contour Neurovascular System device via standard endovascular procedure.

Sponsors & Collaborators

  • Cerus Endovascular, Inc.

    lead INDUSTRY

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-07-31
Primary Completion
2018-10-31
Completion
2018-10-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02784431 on ClinicalTrials.gov